236 related articles for article (PubMed ID: 26074073)
21. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
22. Quantitative framework for ordered degradation of APC/C substrates.
Lu D; Girard JR; Li W; Mizrak A; Morgan DO
BMC Biol; 2015 Nov; 13():96. PubMed ID: 26573515
[TBL] [Abstract][Full Text] [Related]
23. Kinetochores accelerate or delay APC/C activation by directing Cdc20 to opposing fates.
Kim T; Lara-Gonzalez P; Prevo B; Meitinger F; Cheerambathur DK; Oegema K; Desai A
Genes Dev; 2017 Jun; 31(11):1089-1094. PubMed ID: 28698300
[TBL] [Abstract][Full Text] [Related]
24. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
25. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons.
Kim AH; Puram SV; Bilimoria PM; Ikeuchi Y; Keough S; Wong M; Rowitch D; Bonni A
Cell; 2009 Jan; 136(2):322-36. PubMed ID: 19167333
[TBL] [Abstract][Full Text] [Related]
26. High-Throughput Automated Single-Cell Imaging Analysis Reveals Dynamics of Glioblastoma Stem Cell Population During State Transition.
Chumakova AP; Hitomi M; Sulman EP; Lathia JD
Cytometry A; 2019 Mar; 95(3):290-301. PubMed ID: 30729665
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional and post-transcriptional regulation of Cdc20 during the spindle assembly checkpoint in S. cerevisiae.
Wang R; Burton JL; Solomon MJ
Cell Signal; 2017 May; 33():41-48. PubMed ID: 28189585
[TBL] [Abstract][Full Text] [Related]
29. Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
Balça-Silva J; do Carmo A; Tão H; Rebelo O; Barbosa M; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC; Moreira JN
Exp Cell Res; 2018 Sep; 370(1):68-77. PubMed ID: 29902537
[TBL] [Abstract][Full Text] [Related]
30. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.
Miao H; Gale NW; Guo H; Qian J; Petty A; Kaspar J; Murphy AJ; Valenzuela DM; Yancopoulos G; Hambardzumyan D; Lathia JD; Rich JN; Lee J; Wang B
Oncogene; 2015 Jan; 34(5):558-67. PubMed ID: 24488013
[TBL] [Abstract][Full Text] [Related]
31. REST regulates oncogenic properties of glioblastoma stem cells.
Kamal MM; Sathyan P; Singh SK; Zinn PO; Marisetty AL; Liang S; Gumin J; El-Mesallamy HO; Suki D; Colman H; Fuller GN; Lang FF; Majumder S
Stem Cells; 2012 Mar; 30(3):405-14. PubMed ID: 22228704
[TBL] [Abstract][Full Text] [Related]
32. Targeting Cdc20 for cancer therapy.
Jeong SM; Bui QT; Kwak M; Lee JY; Lee PC
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188824. PubMed ID: 36243246
[TBL] [Abstract][Full Text] [Related]
33. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.
Mahlokozera T; Patel B; Chen H; Desouza P; Qu X; Mao DD; Hafez D; Yang W; Taiwo R; Paturu M; Salehi A; Gujar AD; Dunn GP; Mosammaparast N; Petti AA; Yano H; Kim AH
Nat Commun; 2021 Nov; 12(1):6321. PubMed ID: 34732716
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of mitochondrial UQCRB inhibits cancer stem cell-like properties in glioblastoma.
Jung N; Kwon HJ; Jung HJ
Int J Oncol; 2018 Jan; 52(1):241-251. PubMed ID: 29115404
[TBL] [Abstract][Full Text] [Related]
36. Cdc20: At the Crossroads between Chromosome Segregation and Mitotic Exit.
Kapanidou M; Curtis NL; Bolanos-Garcia VM
Trends Biochem Sci; 2017 Mar; 42(3):193-205. PubMed ID: 28202332
[TBL] [Abstract][Full Text] [Related]
37. Oscillation of Cdc20-APC/C-mediated CAMDI stability is critical for cortical neuron migration.
Okuda S; Sato M; Kato S; Nagashima S; Inatome R; Yanagi S; Fukuda T
J Biol Chem; 2021 Aug; 297(2):100986. PubMed ID: 34298015
[TBL] [Abstract][Full Text] [Related]
38. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
39. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
40. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
Crawford LJ; Anderson G; Johnston CK; Irvine AE
Oncotarget; 2016 Oct; 7(43):70481-70493. PubMed ID: 27655696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
